Iconic landmarks in the national capital, including Parliament House, Rashtrapati Bhavan, North Block, South Block and India Gate, were illuminated in teal blue on Tuesday evening to mark Cervical Cancer Elimination Day of Action.

Visuals from central Delhi showed prominent government buildings and monuments glowing in teal, the global awareness colour for cervical cancer, as part of efforts to raise awareness about prevention, early screening and timely treatment of the disease.

Observed annually on November 17, the day commemorates the launch of the World Health Organization's (WHO) Global Strategy to Accelerate the Elimination of Cervical Cancer in 2020. Landmarks across the world are illuminated in teal to highlight the global campaign against the disease.

This year's campaign carries the theme "Together We Can Eliminate Cervical Cancer", emphasising the need to achieve the WHO's 90-70-90 targets by 2030.

What the 90-70-90 targets mean

Under the targets, 90 per cent of girls are to be fully vaccinated against the Human Papillomavirus (HPV) by the age of 15, 70 per cent of women are to be screened using a high-performance test by the ages of 35 and 45, and 90 per cent of women diagnosed with cervical disease are to receive appropriate treatment.

Cervical cancer is among the major causes of cancer deaths among women in India, yet it is largely preventable through vaccination against HPV, regular screening and early treatment. The WHO defines elimination as reducing cervical cancer incidence to fewer than four new cases per 100,000 women every year.

In 2020, 194 countries committed to the WHO's global strategy to eliminate cervical cancer as a public health problem. Six years on, the gap between the ambition and the ground reality remains wide, particularly in low and middle-income countries where access to vaccination, screening, diagnosis and treatment is still limited.

The screening gap

On November 17, the WHO highlighted a major gap in prevention: three in five women aged 30 to 49 have never been screened for cervical cancer.

Only 2 per cent of women in low and middle-income countries had undergone HPV testing in the preceding five years, compared with 32 per cent in high-income countries, the WHO data showed.

Dr Tejinder Singh, professor and lead consultant in medical and precision oncology at Apollo Hospitals, Navi Mumbai, said a major cause of delayed diagnosis in India is the lack of regular screening. "Cervical cancer is largely preventable, yet many women in India continue to be diagnosed at an advanced stage," he said.

Dr Anup R Hegde, attending consultant medical oncologist at KIMS Hospitals, Electronic City, Bengaluru, said India needs to move beyond awareness initiatives and focus on measurable preventive and treatment interventions, strengthening the healthcare system so that vaccination, screening and treatment actually reach women.

India's vaccination push

India has stepped up its preventive healthcare efforts against cervical cancer. In February 2026, Prime Minister Narendra Modi launched a nationwide HPV vaccination drive to provide free vaccination to 14-year-old girls at government health facilities.

The WHO recommends that girls aged 9 to 14 years receive the HPV vaccine, with one or two doses depending on age and immune status. Vaccination protects against the virus that causes most cervical cancers, but experts stress that even vaccinated women still need regular screening, since the vaccine does not cover every cancer-causing strain of the virus.

The teal illumination in Delhi was part of a worldwide show of solidarity, with monuments in several countries lit up in the same colour. The message from health experts on the day was consistent: cervical cancer can be eliminated, but only if vaccination, screening and treatment move from targets on paper to services that reach every woman.